CCMG
UTHR icon

Clark Capital Management Group’s United Therapeutics UTHR Stock Holding History

Clark Capital Management Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.22M Sell
2,245
-989
-31% -$557K 0.01% 321
2026
Q1 		$1.92M Buy
3,234
+2,732
+544% +$1.36M 0.01% 276
2025
Q4 		$245K Buy
+502
New +$234K ﹤0.01% 462
2025
Q3 		– Sell
-95,256
Closed -$27.4M – 471
2025
Q2 		$27.4M Buy
95,256
+892
+0.9% +$267K 0.19% 144
2025
Q1 		$29.1M Sell
94,364
-94,977
-50% -$32.5M 0.21% 131
2024
Q4 		$66.8M Buy
189,341
+7,053
+4% +$2.59M 0.47% 61
2024
Q3 		$65.3M Buy
182,288
+6,375
+4% +$2.15M 0.45% 69
2024
Q2 		$56M Buy
175,913
+61,318
+54% +$16.2M 0.41% 68
2024
Q1 		$26.3M Buy
114,595
+3,020
+3% +$681K 0.2% 144
2023
Q4 		$24.5M Sell
111,575
-20,120
-15% -$4.64M 0.2% 138
2023
Q3 		$29.7M Buy
131,695
+31,721
+32% +$7.31M 0.3% 118
2023
Q2 		$22.1M Buy
99,974
+1,196
+1% +$265K 0.2% 136
2023
Q1 		$22.1M Buy
98,778
+2,674
+3% +$659K 0.25% 136
2022
Q4 		$26.7M Buy
96,104
+83,425
+658% +$21.1M 0.25% 121
2022
Q3 		$2.65M Buy
12,679
+209
+2% +$46.7K 0.03% 193
2022
Q2 		$2.94M Sell
12,470
-8
-0.1% -$1.63K 0.04% 183
2022
Q1 		$2.24M Sell
12,478
-6,079
-33% -$1.16M 0.03% 227
2021
Q4 		$4.01M Sell
18,557
-764
-4% -$150K 0.05% 181
2021
Q3 		$3.57M Buy
19,321
+799
+4% +$157K 0.05% 183
2021
Q2 		$3.32M Buy
18,522
+2,592
+16% +$494K 0.05% 203
2021
Q1 		$2.67M Sell
15,930
-7,511
-32% -$1.25M 0.04% 209
2020
Q4 		$3.56M Buy
+23,441
New +$3.08M 0.06% 188
2020
Q3 		– Sell
-25,510
Closed -$3.09M – 338
2020
Q2 		$3.09M Sell
25,510
-8,137
-24% -$916K 0.06% 171
2020
Q1 		$3.19M Buy
33,647
+7,402
+28% +$704K 0.08% 144
2019
Q4 		$2.31M Buy
+26,245
New +$2.31M 0.05% 179

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Clark Capital Management Group's UTHR Position: Q2 2026 in Review

Clark Capital Management Group reduced its United Therapeutics (UTHR) stake by 31% in Q2 2026, selling an estimated $557K and leaving 2,245 shares worth $1.22M. The position accounts for 0.01% of the portfolio, ranked #321.

Clark Capital Management Group first reported a position in UTHR in Q4 2019 and has held it in 25 quarters since. The position peaked at $66.8M in Q4 2024. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Clark Capital Management Group held 2,245 shares of United Therapeutics worth $1.22M as of Q2 2026.
  • Clark Capital Management Group sold 989 United Therapeutics shares in Q2 2026, an estimated $557K.
  • United Therapeutics made up 0.01% of Clark Capital Management Group's portfolio in Q2 2026, its #321 holding.
  • Clark Capital Management Group first reported a position in United Therapeutics in Q4 2019 and has held it in 25 quarters since.
  • Clark Capital Management Group's United Therapeutics position peaked at $66.8M in Q4 2024.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Clark Capital Management Group's 13F filing for Q2 2026, filed 11 Aug 2026.